ARCHIVES

Studies Link Age-Dependent Outcome To Immune Cells

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Appropriations: Senate Committee Approves 4.5 Percent Cut To Defense Dept. Cancer Research Funding

July 25, 2014

ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says.

July 28, 2006

Funding Opporunities: Program Announcments

January 15, 1999

Clinical Trials: NCI Puts State of Science Meetings on the Web

May 12, 2000

Treatment IND or GM-CSF Is Approved

October 5, 1990

Two Regorafenib Trials Demonstrate Efficacy, Improve Overall and Progression-Free Survival

December 28, 2012